159 related articles for article (PubMed ID: 37933840)
1. The forkhead DNA-binding domain binds specific G2-rich RNA sequences.
Zutterling C; Todeschini AL; Fourmy D; Busso D; Veaute X; Ducongé F; Veitia RA
Nucleic Acids Res; 2023 Dec; 51(22):12367-12380. PubMed ID: 37933840
[TBL] [Abstract][Full Text] [Related]
2. The FOXP2 forkhead domain binds to a variety of DNA sequences with different rates and affinities.
Webb H; Steeb O; Blane A; Rotherham L; Aron S; Machanick P; Dirr H; Fanucchi S
J Biochem; 2017 Jul; 162(1):45-54. PubMed ID: 28104810
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel protein partners of the transcription factor FOXL2 provides insights into its physiopathological roles.
L'Hôte D; Georges A; Todeschini AL; Kim JH; Benayoun BA; Bae J; Veitia RA
Hum Mol Genet; 2012 Jul; 21(14):3264-74. PubMed ID: 22544055
[TBL] [Abstract][Full Text] [Related]
4. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
[TBL] [Abstract][Full Text] [Related]
5. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.
Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E
Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316
[TBL] [Abstract][Full Text] [Related]
6. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
[TBL] [Abstract][Full Text] [Related]
7. FOXO4 Transactivation Domain Interaction with Forkhead DNA Binding Domain and Effect on Selective DNA Recognition for Transcription Initiation.
Kim J; Ahn D; Park CJ
J Mol Biol; 2021 Feb; 433(4):166808. PubMed ID: 33450250
[TBL] [Abstract][Full Text] [Related]
8. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
[TBL] [Abstract][Full Text] [Related]
9. FOXL2 and FOXA1 cooperatively assemble on the TP53 promoter in alternative dimer configurations.
Choi Y; Luo Y; Lee S; Jin H; Yoon HJ; Hahn Y; Bae J; Lee HH
Nucleic Acids Res; 2022 Aug; 50(15):8929-8946. PubMed ID: 35920317
[TBL] [Abstract][Full Text] [Related]
10. Essential but differential role of FOXL2wt and FOXL2C134W in GDF-9 stimulation of follistatin transcription in co-operation with Smad3 in the human granulosa cell line COV434.
Nonis D; McTavish KJ; Shimasaki S
Mol Cell Endocrinol; 2013 Jun; 372(1-2):42-8. PubMed ID: 23523567
[TBL] [Abstract][Full Text] [Related]
11. Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene.
Pisarska MD; Bae J; Klein C; Hsueh AJ
Endocrinology; 2004 Jul; 145(7):3424-33. PubMed ID: 15059956
[TBL] [Abstract][Full Text] [Related]
12. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.
Carles A; Trigo-Gonzalez G; Cao Q; Cheng SG; Moksa M; Bilenky M; Huntsman DG; Morin GB; Hirst M
Cancer Res; 2020 Sep; 80(17):3480-3491. PubMed ID: 32641414
[TBL] [Abstract][Full Text] [Related]
13. A Key Evolutionary Mutation Enhances DNA Binding of the FOXP2 Forkhead Domain.
Morris G; Fanucchi S
Biochemistry; 2016 Apr; 55(13):1959-67. PubMed ID: 26950495
[TBL] [Abstract][Full Text] [Related]
14. SMADs and FOXL2 synergistically regulate murine FSHbeta transcription via a conserved proximal promoter element.
Tran S; Lamba P; Wang Y; Bernard DJ
Mol Endocrinol; 2011 Jul; 25(7):1170-83. PubMed ID: 21622537
[TBL] [Abstract][Full Text] [Related]
15. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
[TBL] [Abstract][Full Text] [Related]
16. Foxl2 up-regulates aromatase gene transcription in a female-specific manner by binding to the promoter as well as interacting with ad4 binding protein/steroidogenic factor 1.
Wang DS; Kobayashi T; Zhou LY; Paul-Prasanth B; Ijiri S; Sakai F; Okubo K; Morohashi K; Nagahama Y
Mol Endocrinol; 2007 Mar; 21(3):712-25. PubMed ID: 17192407
[TBL] [Abstract][Full Text] [Related]
17. FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells.
Anttonen M; Pihlajoki M; Andersson N; Georges A; L'hôte D; Vattulainen S; Färkkilä A; Unkila-Kallio L; Veitia RA; Heikinheimo M
PLoS One; 2014; 9(1):e85545. PubMed ID: 24416423
[TBL] [Abstract][Full Text] [Related]
18. Mutant FOXL2
Weis-Banke SE; Lerdrup M; Kleine-Kohlbrecher D; Mohammad F; Sidoli S; Jensen ON; Yanase T; Nakamura T; Iwase A; Stylianou A; Abu-Rustum NR; Aghajanian C; Soslow R; Da Cruz Paula A; Koche RP; Weigelt B; Christensen J; Helin K; Cloos PAC
Cancer Res; 2020 Sep; 80(17):3466-3479. PubMed ID: 32641411
[TBL] [Abstract][Full Text] [Related]
19.
Mubeen A; Parra-Herran C
J Clin Pathol; 2023 Dec; 76(12):798-801. PubMed ID: 37798106
[TBL] [Abstract][Full Text] [Related]
20. DNA-binding properties of the MADS-domain transcription factor SEPALLATA3 and mutant variants characterized by SELEX-seq.
Käppel S; Eggeling R; Rümpler F; Groth M; Melzer R; Theißen G
Plant Mol Biol; 2021 Mar; 105(4-5):543-557. PubMed ID: 33486697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
